nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.685	1	CbGbCtD
Oxtriphylline—PDE4C—tongue—amyotrophic lateral sclerosis	0.0247	0.104	CbGeAlD
Oxtriphylline—ADORA1—nerve—amyotrophic lateral sclerosis	0.0159	0.0667	CbGeAlD
Oxtriphylline—HDAC2—tongue—amyotrophic lateral sclerosis	0.0153	0.0643	CbGeAlD
Oxtriphylline—HDAC2—hindbrain—amyotrophic lateral sclerosis	0.0117	0.0493	CbGeAlD
Oxtriphylline—PDE4C—brainstem—amyotrophic lateral sclerosis	0.0108	0.0456	CbGeAlD
Oxtriphylline—HDAC2—embryo—amyotrophic lateral sclerosis	0.00734	0.0308	CbGeAlD
Oxtriphylline—HDAC2—brainstem—amyotrophic lateral sclerosis	0.00672	0.0283	CbGeAlD
Oxtriphylline—PDE4C—nervous system—amyotrophic lateral sclerosis	0.00568	0.0239	CbGeAlD
Oxtriphylline—PDE3B—cerebellum—amyotrophic lateral sclerosis	0.00564	0.0237	CbGeAlD
Oxtriphylline—PDE4C—central nervous system—amyotrophic lateral sclerosis	0.00547	0.023	CbGeAlD
Oxtriphylline—ADORA2B—nervous system—amyotrophic lateral sclerosis	0.00496	0.0209	CbGeAlD
Oxtriphylline—ADORA2A—spinal cord—amyotrophic lateral sclerosis	0.0049	0.0206	CbGeAlD
Oxtriphylline—ADORA2B—central nervous system—amyotrophic lateral sclerosis	0.00478	0.0201	CbGeAlD
Oxtriphylline—ADORA1—medulla oblongata—amyotrophic lateral sclerosis	0.00475	0.02	CbGeAlD
Oxtriphylline—PDE4D—cerebellum—amyotrophic lateral sclerosis	0.0047	0.0198	CbGeAlD
Oxtriphylline—HDAC2—medulla oblongata—amyotrophic lateral sclerosis	0.00469	0.0197	CbGeAlD
Oxtriphylline—ADORA2B—cerebellum—amyotrophic lateral sclerosis	0.00467	0.0196	CbGeAlD
Oxtriphylline—PDE3B—brain—amyotrophic lateral sclerosis	0.00458	0.0193	CbGeAlD
Oxtriphylline—PDE4C—brain—amyotrophic lateral sclerosis	0.00434	0.0182	CbGeAlD
Oxtriphylline—ADORA1—spinal cord—amyotrophic lateral sclerosis	0.00423	0.0178	CbGeAlD
Oxtriphylline—PDE4A—cerebellum—amyotrophic lateral sclerosis	0.00416	0.0175	CbGeAlD
Oxtriphylline—ADORA2A—nervous system—amyotrophic lateral sclerosis	0.00413	0.0174	CbGeAlD
Oxtriphylline—ADORA2A—central nervous system—amyotrophic lateral sclerosis	0.00398	0.0167	CbGeAlD
Oxtriphylline—ADORA2A—cerebellum—amyotrophic lateral sclerosis	0.00389	0.0163	CbGeAlD
Oxtriphylline—PDE4D—brain—amyotrophic lateral sclerosis	0.00382	0.0161	CbGeAlD
Oxtriphylline—ADORA2B—brain—amyotrophic lateral sclerosis	0.00379	0.016	CbGeAlD
Oxtriphylline—ADORA1—nervous system—amyotrophic lateral sclerosis	0.00357	0.015	CbGeAlD
Oxtriphylline—HDAC2—nervous system—amyotrophic lateral sclerosis	0.00352	0.0148	CbGeAlD
Oxtriphylline—PDE4B—medulla oblongata—amyotrophic lateral sclerosis	0.00351	0.0148	CbGeAlD
Oxtriphylline—PDE3A—cerebellum—amyotrophic lateral sclerosis	0.00344	0.0145	CbGeAlD
Oxtriphylline—ADORA1—central nervous system—amyotrophic lateral sclerosis	0.00343	0.0144	CbGeAlD
Oxtriphylline—HDAC2—central nervous system—amyotrophic lateral sclerosis	0.00339	0.0143	CbGeAlD
Oxtriphylline—PDE4A—brain—amyotrophic lateral sclerosis	0.00338	0.0142	CbGeAlD
Oxtriphylline—ADORA1—cerebellum—amyotrophic lateral sclerosis	0.00336	0.0141	CbGeAlD
Oxtriphylline—HDAC2—cerebellum—amyotrophic lateral sclerosis	0.00331	0.0139	CbGeAlD
Oxtriphylline—ADORA2A—brain—amyotrophic lateral sclerosis	0.00316	0.0133	CbGeAlD
Oxtriphylline—PDE4B—spinal cord—amyotrophic lateral sclerosis	0.00313	0.0132	CbGeAlD
Oxtriphylline—SLC22A7—brain—amyotrophic lateral sclerosis	0.00313	0.0132	CbGeAlD
Oxtriphylline—PDE3A—brain—amyotrophic lateral sclerosis	0.0028	0.0118	CbGeAlD
Oxtriphylline—ADORA1—brain—amyotrophic lateral sclerosis	0.00273	0.0115	CbGeAlD
Oxtriphylline—HDAC2—brain—amyotrophic lateral sclerosis	0.00269	0.0113	CbGeAlD
Oxtriphylline—PDE4B—nervous system—amyotrophic lateral sclerosis	0.00264	0.0111	CbGeAlD
Oxtriphylline—PDE4B—central nervous system—amyotrophic lateral sclerosis	0.00254	0.0107	CbGeAlD
Oxtriphylline—PDE4B—cerebellum—amyotrophic lateral sclerosis	0.00248	0.0104	CbGeAlD
Oxtriphylline—PDE4B—brain—amyotrophic lateral sclerosis	0.00202	0.00848	CbGeAlD
Oxtriphylline—HDAC2—Signaling by NOTCH—TP53—amyotrophic lateral sclerosis	0.000154	0.00199	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000154	0.00199	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000154	0.00199	CbGpPWpGaD
Oxtriphylline—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000153	0.00198	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000152	0.00197	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.00015	0.00194	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000149	0.00193	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000149	0.00192	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000147	0.0019	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000147	0.0019	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000147	0.0019	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000145	0.00188	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000145	0.00187	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000145	0.00187	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000144	0.00187	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000143	0.00185	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000143	0.00185	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000142	0.00184	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000141	0.00182	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000139	0.0018	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000138	0.00178	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000136	0.00176	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000136	0.00176	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000135	0.00175	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000134	0.00174	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000133	0.00172	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000132	0.00171	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000131	0.0017	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000131	0.00169	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000131	0.00169	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000131	0.00169	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000129	0.00167	CbGpPWpGaD
Oxtriphylline—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—amyotrophic lateral sclerosis	0.000129	0.00167	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000128	0.00166	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000127	0.00164	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000127	0.00164	CbGpPWpGaD
Oxtriphylline—HDAC2—Direct p53 effectors—TP53—amyotrophic lateral sclerosis	0.000126	0.00163	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000126	0.00163	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000125	0.00162	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000125	0.00162	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000125	0.00161	CbGpPWpGaD
Oxtriphylline—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000125	0.00161	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000123	0.0016	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000123	0.00159	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000122	0.00157	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00012	0.00155	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.00012	0.00155	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000119	0.00153	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000117	0.00151	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000116	0.00151	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000115	0.00149	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000114	0.00148	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000114	0.00148	CbGpPWpGaD
Oxtriphylline—ADORA1—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000114	0.00147	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000113	0.00146	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000112	0.00145	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—CST3—amyotrophic lateral sclerosis	0.000111	0.00144	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000111	0.00144	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	0.000111	0.00144	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000111	0.00144	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00011	0.00142	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000109	0.00141	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000108	0.0014	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000106	0.00138	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000106	0.00138	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000106	0.00137	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000106	0.00137	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000105	0.00136	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000105	0.00136	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000104	0.00135	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	0.000103	0.00134	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000103	0.00133	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000101	0.00131	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000101	0.0013	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	9.92e-05	0.00128	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	9.84e-05	0.00127	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	9.77e-05	0.00126	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	9.65e-05	0.00125	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	9.65e-05	0.00125	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	9.65e-05	0.00125	CbGpPWpGaD
Oxtriphylline—HDAC2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	9.44e-05	0.00122	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	9.39e-05	0.00121	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	9.36e-05	0.00121	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	9.33e-05	0.00121	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	9.29e-05	0.0012	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	9.22e-05	0.00119	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.22e-05	0.00119	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—C3—amyotrophic lateral sclerosis	9.21e-05	0.00119	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	9.18e-05	0.00119	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—IGF1—amyotrophic lateral sclerosis	9.14e-05	0.00118	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	9.04e-05	0.00117	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.97e-05	0.00116	CbGpPWpGaD
Oxtriphylline—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.95e-05	0.00116	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	8.93e-05	0.00116	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.82e-05	0.00114	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.79e-05	0.00114	CbGpPWpGaD
Oxtriphylline—ADORA2A—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	8.77e-05	0.00114	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.76e-05	0.00113	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.7e-05	0.00113	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	8.67e-05	0.00112	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	8.58e-05	0.00111	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.56e-05	0.00111	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.53e-05	0.0011	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	8.43e-05	0.00109	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.42e-05	0.00109	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.21e-05	0.00106	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	8.2e-05	0.00106	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.16e-05	0.00106	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.15e-05	0.00105	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.11e-05	0.00105	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—CASP9—amyotrophic lateral sclerosis	8.08e-05	0.00105	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.03e-05	0.00104	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.02e-05	0.00104	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.93e-05	0.00103	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.77e-05	0.00101	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.65e-05	0.000989	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.64e-05	0.000989	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.63e-05	0.000987	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.54e-05	0.000976	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.52e-05	0.000973	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	7.46e-05	0.000966	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.44e-05	0.000962	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.28e-05	0.000942	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	7.17e-05	0.000928	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.16e-05	0.000926	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.08e-05	0.000916	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.07e-05	0.000915	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.07e-05	0.000915	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.98e-05	0.000903	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—ERBB4—amyotrophic lateral sclerosis	6.92e-05	0.000895	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.86e-05	0.000888	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	6.85e-05	0.000887	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	6.85e-05	0.000887	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.82e-05	0.000882	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.74e-05	0.000871	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.65e-05	0.000861	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.55e-05	0.000847	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.45e-05	0.000835	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.39e-05	0.000827	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.34e-05	0.00082	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.34e-05	0.00082	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	6.27e-05	0.000811	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.26e-05	0.000809	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.25e-05	0.000808	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.23e-05	0.000806	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—TP53—amyotrophic lateral sclerosis	6.19e-05	0.000801	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.15e-05	0.000796	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.06e-05	0.000784	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—VEGFA—amyotrophic lateral sclerosis	5.97e-05	0.000772	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.94e-05	0.000769	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.89e-05	0.000762	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.86e-05	0.000758	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.83e-05	0.000755	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.83e-05	0.000754	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.82e-05	0.000753	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.77e-05	0.000746	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.7e-05	0.000738	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.7e-05	0.000737	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.66e-05	0.000732	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—TP53—amyotrophic lateral sclerosis	5.64e-05	0.00073	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.53e-05	0.000715	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.53e-05	0.000715	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.49e-05	0.00071	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	5.48e-05	0.000709	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.44e-05	0.000704	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.42e-05	0.000701	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—APOE—amyotrophic lateral sclerosis	5.35e-05	0.000692	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.31e-05	0.000687	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.26e-05	0.000681	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.18e-05	0.00067	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.15e-05	0.000666	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.06e-05	0.000655	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.04e-05	0.000652	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	4.96e-05	0.000641	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.85e-05	0.000627	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.85e-05	0.000627	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.82e-05	0.000624	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.81e-05	0.000622	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.79e-05	0.00062	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.69e-05	0.000607	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.56e-05	0.000589	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.51e-05	0.000584	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—TP53—amyotrophic lateral sclerosis	4.51e-05	0.000583	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.5e-05	0.000583	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.46e-05	0.000577	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.39e-05	0.000567	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.25e-05	0.00055	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.24e-05	0.000548	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.18e-05	0.000541	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.03e-05	0.000521	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.98e-05	0.000515	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.87e-05	0.000501	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	3.76e-05	0.000486	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.75e-05	0.000485	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.74e-05	0.000484	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.73e-05	0.000482	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.7e-05	0.000479	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.69e-05	0.000477	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PTGS2—amyotrophic lateral sclerosis	3.67e-05	0.000474	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.5e-05	0.000452	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.48e-05	0.000451	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	3.47e-05	0.000448	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.38e-05	0.000437	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.27e-05	0.000424	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.22e-05	0.000417	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.19e-05	0.000413	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.16e-05	0.000408	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.14e-05	0.000406	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.1e-05	0.000401	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.09e-05	0.0004	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.07e-05	0.000397	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.04e-05	0.000394	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.98e-05	0.000386	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.9e-05	0.000375	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.88e-05	0.000373	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.87e-05	0.000371	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.86e-05	0.000371	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.85e-05	0.000368	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.84e-05	0.000367	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.82e-05	0.000365	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.78e-05	0.000359	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.73e-05	0.000354	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.71e-05	0.000351	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.68e-05	0.000347	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.6e-05	0.000337	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.6e-05	0.000336	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.53e-05	0.000327	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.44e-05	0.000315	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.41e-05	0.000311	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.38e-05	0.000308	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.37e-05	0.000307	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.25e-05	0.000291	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.22e-05	0.000287	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.16e-05	0.00028	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.1e-05	0.000272	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.09e-05	0.000271	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.07e-05	0.000267	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.02e-05	0.000262	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.97e-05	0.000254	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.91e-05	0.000247	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.88e-05	0.000243	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.84e-05	0.000238	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.82e-05	0.000235	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.78e-05	0.00023	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.53e-05	0.000198	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.53e-05	0.000198	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.42e-05	0.000184	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.41e-05	0.000182	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.16e-05	0.00015	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.93e-06	0.000103	CbGpPWpGaD
